More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$204.31B
EPS
14.23
P/E ratio
28.9
Price to sales
5.61
Dividend yield
2.657%
Beta
0.466454
Previous close
$374.75
Today's open
$375.26
Day's range
$374.74 - $381.78
52 week range
$261.43 - $385.12
show more
CEO
Robert A. Bradway
Employees
28000
Headquarters
Thousand Oaks, CA
Exchange
Nasdaq Global Select
Shares outstanding
538480671
Issue type
Common Stock
Healthcare
Pharmaceuticals
AMGEN TO PRESENT AT THE 46TH ANNUAL TD COWEN HEALTH CARE CONFERENCE
THOUSAND OAKS, Calif., Feb. 24, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 46th Annual TD Cowen Health Care Conference at 1:10 p.m.
PRNewsWire • 3 hours ago

Why Amgen (AMGN) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research • Feb 23, 2026

Harbor Large Cap Value Fund Q4 2025 Portfolio Review
During the fourth quarter, the Harbor Large Cap Value Fund returned 1.26%, underperforming its benchmark, the Russell 1000® Value Index, which returned 3.81%, and underperforming the 2.66% return of the S&P 500 Index. The top five contributors to relative performance during the fourth quarter were: Parker Hannifin, Capital One Financial, Amgen, Merck, and Danaher. The bottom five detractors from relative performance were: Lennar, Uber, Sony, Microsoft, and Teledyne Technologies.
Seeking Alpha • Feb 23, 2026

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Zacks Investment Research • Feb 20, 2026

Amgen Inc. (AMGN) Presents at Citi's 2026 Virtual Oncology Leadership Summit Transcript
Amgen Inc. (AMGN) Presents at Citi's 2026 Virtual Oncology Leadership Summit Transcript
Seeking Alpha • Feb 18, 2026

AMGEN TO PRESENT AT CITI'S 2026 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT
THOUSAND OAKS, Calif., Feb. 13, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Citi's 2026 Virtual Oncology Leadership Summit at 12:15 p.m.
PRNewsWire • Feb 13, 2026

Prices, pipelines and patent cliffs: Inside pharma's big reset
Pharma earnings weren't the main focus for drugmakers this quarter. "2025 was about understanding kind of the rules of the future of the game," McKinsey Senior Partner Greg Graves told CNBC.
CNBC • Feb 13, 2026

Amgen Inc. (AMGN) Presents at Piper Sandler Virtual Novel Targets in Immunology Symposium Transcript
Amgen Inc. (AMGN) Presents at Piper Sandler Virtual Novel Targets in Immunology Symposium Transcript
Seeking Alpha • Feb 13, 2026

These 32 favorite stocks signal the bull market is running on fumes
The S&P 500 sectors that top investment newsletters currently like most are strongest at market peaks.
Market Watch • Feb 12, 2026

Amgen (AMGN) is a Top-Ranked Momentum Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research • Feb 11, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Amgen Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.